Annual SG&A
$24.86 M
+$5.94 M+31.41%
31 December 2023
Summary:
Eliem Therapeutics annual selling, general & administrative expenses is currently $24.86 million, with the most recent change of +$5.94 million (+31.41%) on 31 December 2023. During the last 3 years, it has risen by +$22.44 million (+925.32%). ELYM annual SG&A is now at all-time high.ELYM Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$5.49 M
+$1.82 M+49.77%
30 September 2024
Summary:
Eliem Therapeutics quarterly selling, general & administrative expenses is currently $5.49 million, with the most recent change of +$1.82 million (+49.77%) on 30 September 2024. Over the past year, it has increased by +$3.37 million (+158.45%). ELYM quarterly SG&A is now -69.00% below its all-time high of $17.72 million, reached on 31 March 2023.ELYM Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$747.68 M
-$69.12 M-10.19%
30 September 2024
Summary:
Eliem Therapeutics TTM selling, general & administrative expenses is currently -$747.68 million, with the most recent change of -$69.12 million (-10.19%) on 30 September 2024. Over the past year, it has dropped by -$775.18 million (-2819.23%). ELYM TTM SG&A is now -2557.38% below its all-time high of $31.77 million, reached on 31 March 2023.ELYM TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELYM Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.4% | +158.4% | -2819.2% |
| 3 y3 years | +925.3% | +61.8% | -7530.0% |
| 5 y5 years | - | - | - |
ELYM Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +925.3% | -69.0% | +186.9% | -282.6% | at low |
| 5 y | 5 years | at high | +3572.7% | -69.0% | +2114.5% | -2557.4% | at low |
| alltime | all time | at high | +3572.7% | -69.0% | +2114.5% | -2557.4% | at low |
Eliem Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.49 M(+49.8%) | $13.07 M(+34.7%) |
| June 2024 | - | $3.67 M(+91.6%) | $9.70 M(+7.1%) |
| Mar 2024 | - | $1.91 M(-4.1%) | $9.06 M(-63.6%) |
| Dec 2023 | $24.86 M(+31.4%) | $2.00 M(-6.1%) | $24.86 M(-9.6%) |
| Sept 2023 | - | $2.13 M(-29.8%) | $27.50 M(-7.9%) |
| June 2023 | - | $3.03 M(-82.9%) | $29.86 M(-6.0%) |
| Mar 2023 | - | $17.72 M(+282.9%) | $31.77 M(+67.9%) |
| Dec 2022 | $18.92 M | $4.63 M(+3.1%) | $18.92 M(+4.4%) |
| Sept 2022 | - | $4.49 M(-9.0%) | $18.12 M(+6.4%) |
| June 2022 | - | $4.93 M(+1.2%) | $17.02 M(+13.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $4.87 M(+27.4%) | $15.00 M(+21.5%) |
| Dec 2021 | $12.35 M(+409.3%) | $3.82 M(+12.7%) | $12.35 M(+22.7%) |
| Sept 2021 | - | $3.39 M(+16.5%) | $10.06 M(+44.1%) |
| June 2021 | - | $2.91 M(+31.4%) | $6.98 M(+61.8%) |
| Mar 2021 | - | $2.22 M(+44.3%) | $4.32 M(+77.9%) |
| Dec 2020 | $2.42 M(+258.2%) | $1.54 M(+392.6%) | $2.42 M(+173.1%) |
| Sept 2020 | - | $312.00 K(+25.8%) | $888.00 K(+54.2%) |
| June 2020 | - | $248.00 K(-24.4%) | $576.00 K(+75.6%) |
| Mar 2020 | - | $328.00 K | $328.00 K |
| Dec 2019 | $677.00 K | - | - |
FAQ
- What is Eliem Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Eliem Therapeutics?
- What is Eliem Therapeutics annual SG&A year-on-year change?
- What is Eliem Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Eliem Therapeutics?
- What is Eliem Therapeutics quarterly SG&A year-on-year change?
- What is Eliem Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Eliem Therapeutics?
- What is Eliem Therapeutics TTM SG&A year-on-year change?
What is Eliem Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of ELYM is $24.86 M
What is the all time high annual SG&A for Eliem Therapeutics?
Eliem Therapeutics all-time high annual selling, general & administrative expenses is $24.86 M
What is Eliem Therapeutics annual SG&A year-on-year change?
Over the past year, ELYM annual selling, general & administrative expenses has changed by +$5.94 M (+31.41%)
What is Eliem Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of ELYM is $5.49 M
What is the all time high quarterly SG&A for Eliem Therapeutics?
Eliem Therapeutics all-time high quarterly selling, general & administrative expenses is $17.72 M
What is Eliem Therapeutics quarterly SG&A year-on-year change?
Over the past year, ELYM quarterly selling, general & administrative expenses has changed by +$3.37 M (+158.45%)
What is Eliem Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of ELYM is -$747.68 M
What is the all time high TTM SG&A for Eliem Therapeutics?
Eliem Therapeutics all-time high TTM selling, general & administrative expenses is $31.77 M
What is Eliem Therapeutics TTM SG&A year-on-year change?
Over the past year, ELYM TTM selling, general & administrative expenses has changed by -$775.18 M (-2819.23%)